logo

Teva Pharmaceutical Industries Limited (TEVA)



Trade TEVA now with
  Date
  Headline
8/7/2019 7:19:57 AM Teva Q2 Loss Per Share $0.63 Vs Loss $0.24 Last Year
8/7/2019 7:08:03 AM Teva CFO Michael McClellan To Step Down Due To Personal Reasons
7/15/2019 8:36:53 AM Teva Announces FDA Approval Of AirDuo Digihaler Inhalation Powder
7/2/2019 2:34:23 AM Teva To Present FOCUS Exploratory Endpoints Results
7/1/2019 8:41:18 AM Teva Announces Launch Of 1% Sodium Hyaluronate In The U.S.
5/2/2019 7:04:58 AM Teva Q1 Non-GAAP EPS $0.60; GAAP Loss Per Share $0.10
4/23/2019 9:09:48 AM Compass Minerals Names Kevin Crutchfield President And CEO
4/23/2019 9:07:54 AM Teva Discontinues Clinical Development Program For Use Of Fremanezumab In Cluster Headaches
4/10/2019 8:11:36 AM Teva Enters New $2.3 Bln Unsecured Revolving Credit Facility
4/1/2019 8:30:39 AM Teva: AJOVY Gets EU Approval Offering Patients First, Only Anti-CGRP Treatment
3/18/2019 7:05:34 AM Novo Nordisk Settles US Patent Litigation Case On Victoza With Teva